Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > I Think we get news soon on this !
View:
Post by Oden6570 on Feb 14, 2021 6:06am

I Think we get news soon on this !

Perhaps the animal data is in !

Theralase CSO Dr. Arkady Mandel noted that the company is moving forward on an “advanced vaccine and therapy based on standardized anti-viral approaches by optimizing its PDCs and anti-cancer technology platforms to prevent and fight enveloped viruses, including coronaviruses, such as COVID-19. We are pleased to announce very promising early results of our research that has been conducted by Dr. Coombs and his team at UM.

“This is a global pandemic, which requires research partnerships and the combined strength of multidisciplinary teams,” Arkady added. “By joining forces with UM, Theralase believes it can develop an elegant solution that will help mitigate this threat quickly and efficiently. Data in four preclinical models in both infectious disease and oncology strongly suggests that the Theralase technology platform has flexibility and bandwidth to be clinically relevant in destruction of numerous cancers and pathogens, including enveloped viruses. Now, with a new pandemic raging, Theralase is working on the development of effective mitigation strategies for the novel coronavirus that encompasses prevention of the disease and effective treatment of patients who contract COVID-19.”

U Manitoba inks deal with Theralase to develop coronavirus vaccine and therapy using photodynamic compounds - University-Industry Engagement Week - Tech Transfer Central

Comment by Oden6570 on Feb 14, 2021 6:23am
At least with the University involvment we should be able to easily access Gov funding for trial for covid. After all TLT tech has cured patients from Bladder Cancer yet has struggled to raise Capital or Goverment funding ! Meanwhile the Canadian Goverment subsidizes Oil companies 12 Billion a year ! ( Then suggesting the public pays more in carbon taxes ! Perhaps we need a company namechange to ...more  
Comment by floatinketucky on Feb 14, 2021 7:09am
Published: August 25th, 2020
Comment by Rumpl3StiltSkin on Feb 14, 2021 10:05am
I'm thinkin' nebulized Rutherrin activated by x-ray. Should be easy to roll out super fast if it works.
Comment by menoalittle on Feb 14, 2021 10:47am
>> I'm thinkin' nebulized Rutherrin activated by x-ray. yeah, a CT scan would do a lot more than mere 3D images if prepped with a bit of Rutherrin instead of contrast material, eh?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250